TY - JOUR
T1 - 22S-Butyl-1α,24R-dihydroxyvitamin D3
T2 - Recovery of vitamin D receptor agonistic activity
AU - Inaba, Yuka
AU - Nakabayashi, Makoto
AU - Itoh, Toshimasa
AU - Yoshimoto, Nobuko
AU - Ikura, Teikichi
AU - Ito, Nobutoshi
AU - Shimizu, Masato
AU - Yamamoto, Keiko
N1 - Funding Information:
We are grateful to Prof. Hector F. DeLuca for providing an expression plasmid of rat VDR-LBD, which was used as a PCR-template to make our deletion mutant. This work was supported in part by a Grant-in-Aid for Scientific Research (no. 20590108 ) from the Ministry of Education, Culture, Sports, Science and Technology, Japan .
PY - 2010/7
Y1 - 2010/7
N2 - We recently reported that 22S-butyl-1α,24R-dihydroxyvitamin D3 3 recovers the agonistic activity for vitamin D receptor (VDR), although its 25,26,27-trinor analog 2 is a potent VDR antagonist. To investigate the structural features involved in the recovery of agonism, we crystallized the ternary complex of VDR-ligand-binding domain, ligand 3 and coactivator peptide, and conducted X-ray crystallographic analysis of the complex. Compared with the complex with 2, the complex with 3 recovered the following structural features: a pincer-type hydrogen bond between the 24-hydroxyl group and VDR, the conformation of Leu305, the positioning of His301 and His393, the stability of the complex, and intimate hydrophobic interactions between the ligand and helix 12. In addition, we evaluated the potency of both compounds for recruiting RXR and coactivator. The results indicate that the complex with 3 generates a suitable surface for coactivator recruitment. These studies suggest that the action of 2 as an antagonist is caused by the generation of a surface not suitable for coactivator recruitment due to the lack of hydrophobic interactions with helix 12 as well as insufficient hydrogen bond formation between the 24-hydroxyl group and VDR. We concluded that the action of 3 as an agonist is based on the elimination of these structural defects in the complex with 2.
AB - We recently reported that 22S-butyl-1α,24R-dihydroxyvitamin D3 3 recovers the agonistic activity for vitamin D receptor (VDR), although its 25,26,27-trinor analog 2 is a potent VDR antagonist. To investigate the structural features involved in the recovery of agonism, we crystallized the ternary complex of VDR-ligand-binding domain, ligand 3 and coactivator peptide, and conducted X-ray crystallographic analysis of the complex. Compared with the complex with 2, the complex with 3 recovered the following structural features: a pincer-type hydrogen bond between the 24-hydroxyl group and VDR, the conformation of Leu305, the positioning of His301 and His393, the stability of the complex, and intimate hydrophobic interactions between the ligand and helix 12. In addition, we evaluated the potency of both compounds for recruiting RXR and coactivator. The results indicate that the complex with 3 generates a suitable surface for coactivator recruitment. These studies suggest that the action of 2 as an antagonist is caused by the generation of a surface not suitable for coactivator recruitment due to the lack of hydrophobic interactions with helix 12 as well as insufficient hydrogen bond formation between the 24-hydroxyl group and VDR. We concluded that the action of 3 as an agonist is based on the elimination of these structural defects in the complex with 2.
KW - Antagonist
KW - Coactivator
KW - Hydrophobic interaction
KW - Nuclear receptor
KW - X-ray crystallography
UR - http://www.scopus.com/inward/record.url?scp=77954760559&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954760559&partnerID=8YFLogxK
U2 - 10.1016/j.jsbmb.2010.02.033
DO - 10.1016/j.jsbmb.2010.02.033
M3 - Article
C2 - 20211257
AN - SCOPUS:77954760559
SN - 0960-0760
VL - 121
SP - 146
EP - 150
JO - Journal of Steroid Biochemistry
JF - Journal of Steroid Biochemistry
IS - 1-2
ER -